Amicus Therapeutics

FOLD

FOLD
Amicus Therapeutics Stock Quote
$7.86 $0.24 3.1%
BATS BZX Real Time Price as of October 11, 2019, 4:00 p.m. EDT View Interactive FOLD Charts

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases.

News & Analysis: Amicus Therapeutics

The Fool has written over 100 articles on Amicus Therapeutics.

All

Market Moves

Earnings











Interactive Chart